Biotech | March 14, 2022
Clarivate deals report highlights emerging trends in biopharma deal-making
RNA, cell & gene therapies, artificial intelligence, CRISPR and oncology-related deals dominate the landscape
RNA, cell & gene therapies, artificial intelligence, CRISPR and oncology-related deals dominate the landscape
The award recognizes and supports promising women scientists
Most recently, Rollins was the Chief Information Officer at UnitedHealthcare
Digital meetings driving international partnering at CPhI Japan as companies search for ingredients suppliers
Lynparza is approved in the US, EU, Japan and several other countries for the treatment of patients with gBRCAm, HER2-negative, metastatic breast cancer previously treated with chemotherapy based on results from the OlympiAD Phase III trial
Use of Wipro Holmes Artificial Intelligence capabilities will lead to faster development of advanced therapeutics, improving patient outcomes
Casimir further differentiates Emmes’ industry-leading rare disease research capabilities
Experts will speak about primary tumours of the nervous system and also the tumours of other body parts which get metastasized to the nervous system
The RI investment comes on the back of three other recently completed transactions in Malaysia and Singapore in the last two months
The team built a multiple ionic device system, each of which had a lithium cobalt oxide channel arranged on a common lithium phosphorus oxynitride electrolyte
Subscribe To Our Newsletter & Stay Updated
